Clinical Trials Browser

Phase 3 × Squamous Cell Carcinoma of Head and Neck × Gefitinib × Clear all

NCT00206219 2011-01-27

Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)

Phase 3 Completed

Squamous Cell Carcinoma of Head and Neck